Hao Chen
- Cancer Research top 5%
- MicroRNA in disease regulation 10
- Molecular Biology top 5%
- Inflammasome and immune disorders 18
- Extracellular vesicles in disease 14
- RNA modifications and cancer 9
- Immunology top 10%
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments 8
- Genetics top 5%
- Inflammatory Bowel Disease 8
-
- Esophageal Cancer Research and Treatment 13
-
- Gastric Cancer Management and Outcomes 10
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hao Chen
203 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Cancer Research 464
- Molecular Biology 1.7k
- Immunology 401
- Gastroenterology 94
- Genetics 166
Countries citing papers authored by Hao Chen
This map shows the geographic impact of Hao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Chen more than expected).
Fields of papers citing papers by Hao Chen
This network shows the impact of papers produced by Hao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Chen. The network helps show where Hao Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | One‐Step Symbiosis of Bimetallic Peroxides Nanoparticles to Induce Ferroptosis/Cuproptosis and Activate cGAS‐STING Pathway for Enhanced Tumor Immunotherapybreakdown → | 2025 | 34 |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 4 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 21 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 7 | |
| 15 | 2023 | 3 | |
| 16 | 2022 | 27 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 25 | |
| 19 | 2019 | 135 | |
| 20 | 2018 | 10 |
About Hao Chen
Hao Chen is a scholar working on Gastroenterology, Cancer Research, Oncology, Molecular Biology and Biological Psychiatry, having authored 224 papers that have together received 3.8k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (18 papers), Extracellular vesicles in disease (14 papers), Esophageal Cancer Research and Treatment (13 papers), MicroRNA in disease regulation (10 papers), Gastric Cancer Management and Outcomes (10 papers), RNA modifications and cancer (9 papers), Gastroesophageal reflux and treatments (8 papers) and Inflammatory Bowel Disease (8 papers). The work is most often cited by research in Cancer Research (464 citations), Molecular Biology (1.7k citations), Immunology (401 citations), Gastroenterology (94 citations) and Genetics (166 citations). Hao Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weihong Sha, Susan Dumais, Edward Cutrell, Rubin Jiang, Sen Xu, Lei Jiang, J.B. Gavin, Xiaoxin Chen, Zewei Zhuo and Runzhi Zhu. Their work appears in journals such as BMC Cancer, Medicine, Scientific Reports, International Journal of Surgery and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.